Official recall notice

FDA DrugClass IINotable

FDA Recall: Furosemide Tablets, USP, 80 mg, 100 Tablets bottles, Rx only, Manufactured by: Leading Pharma, LLC,

Recall date
2026-04-29
Category
Drug
FDA class
Class II

Why it was recalled

Hazard

CGMP Deviations; presence of N-nitroso-Furosemide (NNF) above the recommended intake limit.

Recommended action

What to do

9384 bottles

Product description

CGMP Deviations; presence of N-nitroso-Furosemide (NNF) above the recommended intake limit.

Verify with the official notice →
Share:

Related Recalls

2026-09-21 · FDA_DRUG
FDA Recall: Par Pharmaceutical: Dexmedetomidine HCl in 0.9% Sodium Chloride Injection 400 mcg/100 mL (4 mcg/mL)
Par Pharmaceutical
2026-09-21 · FDA_DRUG
FDA Recall: ICU Medical LLC: 0.9% Sodium Chloride Injection, USP, 100 mL
ICU Medical LLC
2026-09-16 · FDA_DRUG
FDA Recall: Povidone Iodine 1.25% / Proparacaine HCl 0.5% Ophthalmic Solution, 10 mL per dropper bottle, For Off
ImprimisRx NJ LLC
2026-09-16 · FDA_DRUG
FDA Recall: Fluphenazine Hydrochloride Tablets, USP, 1mg, 100-count bottles, Rx Only, Marketed by: Ajanta Pharm
Ajanta Pharma USA Inc